Xiangjin L. Xu
No.156 Xierhuan Road
Fuzhou, 350000, China
Fuzhou, 350000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Correlation analysis between hemoglobin and type 2 diabetic nephropathy: a two-center retrospective study.
Journal: Acta diabetologica
Published: December 16, 2024
Upregulation of Metrnl improves diabetic kidney disease by inhibiting the TGF-β1/Smads signaling pathway: A potential therapeutic target.
Journal: PloS one
Published: April 17, 2024
The role of the STING inflammatory pathway in hepatic damage in psoriasis with type 2 diabetes mellitus.
Journal: Archives of medical science : AMS
Published: December 15, 2023
DPP-4 inhibitor linagliptin ameliorates imiquimod-induced psoriasis-like skin alterations in type 2 diabetic mice by inhibiting the MAPK/NF-κB inflammatory pathway.
Journal: Drug development research
Published: March 03, 2022
DUAL II China: Superior HbA1c reductions and weight loss with insulin degludec/liraglutide (IDegLira) versus insulin degludec in a randomized trial of Chinese people with type 2 diabetes inadequately controlled on basal insulin.
Journal: Diabetes, obesity & metabolism
Published: May 12, 2021
Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study.
Journal: Journal of diabetes research
Published: February 03, 2021
PTPN14 deficiency alleviates podocyte injury through suppressing inflammation and fibrosis by targeting TRIP6 in diabetic nephropathy.
Journal: Biochemical and biophysical research communications
Published: December 06, 2020
Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial.
Journal: The Journal of dermatological treatment
Published: September 23, 2020
Nine-year-old boy with goitre, blepharoptosis and alopecia areata.
Journal: Journal of paediatrics and child health
Published: August 31, 2020
Efficacy and safety of linagliptin as add-on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial.
Journal: Diabetes, obesity & metabolism
Published: July 29, 2020
Efficacy and safety of DBPR108 monotherapy in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled, phase II clinical trial.
Journal: Current medical research and opinion
Published: April 28, 2020
Clinical histopathologic characteristics of lacrimal glands in lacrimal gland prolapse with blepharochalasis
Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
Published: March 19, 2020
Last Updated: 09/26/2026